Cargando…
All-cause mortality and survival in adults with 22q11.2 deletion syndrome
PURPOSE: Given limited data available on long-term outcomes in 22q11.2 deletion syndrome (22q11.2DS), we investigated mortality risk in adults with this microdeletion syndrome. METHODS: We studied 309 well-characterized adults (age ≥17 years) with 22q11.2DS and their 1014 unaffected parents and sibl...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774995/ https://www.ncbi.nlm.nih.gov/pubmed/30948858 http://dx.doi.org/10.1038/s41436-019-0509-y |
_version_ | 1783456139501895680 |
---|---|
author | Van, Lily Heung, Tracy Graffi, Justin Ng, Enoch Malecki, Sarah Van Mil, Spencer Boot, Erik Corral, Maria Chow, Eva W. C. Hodgkinson, Kathleen A. Silversides, Candice Bassett, Anne S. |
author_facet | Van, Lily Heung, Tracy Graffi, Justin Ng, Enoch Malecki, Sarah Van Mil, Spencer Boot, Erik Corral, Maria Chow, Eva W. C. Hodgkinson, Kathleen A. Silversides, Candice Bassett, Anne S. |
author_sort | Van, Lily |
collection | PubMed |
description | PURPOSE: Given limited data available on long-term outcomes in 22q11.2 deletion syndrome (22q11.2DS), we investigated mortality risk in adults with this microdeletion syndrome. METHODS: We studied 309 well-characterized adults (age ≥17 years) with 22q11.2DS and their 1014 unaffected parents and siblings, using a prospective case–control design. We used Cox proportional hazards regression modeling and Kaplan–Meier curves to investigate effects of the 22q11.2 deletion and its associated features on all-cause mortality and survival. RESULTS: The 22q11.2 deletion (hazard ratio [HR] 8.86, 95% CI 2.87–27.37) and major congenital heart disease (CHD; HR 5.03, 95% CI 2.27–11.17), but not intellectual disability or psychotic illness, were significant independent predictors of mortality for adults with 22q11.2DS compared with their siblings. Amongst those with 22q11.2DS, there were 31 deaths that occurred at a median age of 46.4 (range 18.1–68.6) years; a substantial minority had outlived both parents. Probability of survival to age 45 years was approximately 72% for those with major CHD, and 95% for those with no major CHD (p < 0.0001). CONCLUSION: For adults with 22q11.2DS, the 22q11.2 deletion and more severe forms of CHD both contribute to a lower life expectancy than family-based expectations. The results have implications for genetic counseling and anticipatory care. |
format | Online Article Text |
id | pubmed-6774995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-67749952019-10-04 All-cause mortality and survival in adults with 22q11.2 deletion syndrome Van, Lily Heung, Tracy Graffi, Justin Ng, Enoch Malecki, Sarah Van Mil, Spencer Boot, Erik Corral, Maria Chow, Eva W. C. Hodgkinson, Kathleen A. Silversides, Candice Bassett, Anne S. Genet Med Article PURPOSE: Given limited data available on long-term outcomes in 22q11.2 deletion syndrome (22q11.2DS), we investigated mortality risk in adults with this microdeletion syndrome. METHODS: We studied 309 well-characterized adults (age ≥17 years) with 22q11.2DS and their 1014 unaffected parents and siblings, using a prospective case–control design. We used Cox proportional hazards regression modeling and Kaplan–Meier curves to investigate effects of the 22q11.2 deletion and its associated features on all-cause mortality and survival. RESULTS: The 22q11.2 deletion (hazard ratio [HR] 8.86, 95% CI 2.87–27.37) and major congenital heart disease (CHD; HR 5.03, 95% CI 2.27–11.17), but not intellectual disability or psychotic illness, were significant independent predictors of mortality for adults with 22q11.2DS compared with their siblings. Amongst those with 22q11.2DS, there were 31 deaths that occurred at a median age of 46.4 (range 18.1–68.6) years; a substantial minority had outlived both parents. Probability of survival to age 45 years was approximately 72% for those with major CHD, and 95% for those with no major CHD (p < 0.0001). CONCLUSION: For adults with 22q11.2DS, the 22q11.2 deletion and more severe forms of CHD both contribute to a lower life expectancy than family-based expectations. The results have implications for genetic counseling and anticipatory care. Nature Publishing Group US 2019-04-05 2019 /pmc/articles/PMC6774995/ /pubmed/30948858 http://dx.doi.org/10.1038/s41436-019-0509-y Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Article Van, Lily Heung, Tracy Graffi, Justin Ng, Enoch Malecki, Sarah Van Mil, Spencer Boot, Erik Corral, Maria Chow, Eva W. C. Hodgkinson, Kathleen A. Silversides, Candice Bassett, Anne S. All-cause mortality and survival in adults with 22q11.2 deletion syndrome |
title | All-cause mortality and survival in adults with 22q11.2 deletion syndrome |
title_full | All-cause mortality and survival in adults with 22q11.2 deletion syndrome |
title_fullStr | All-cause mortality and survival in adults with 22q11.2 deletion syndrome |
title_full_unstemmed | All-cause mortality and survival in adults with 22q11.2 deletion syndrome |
title_short | All-cause mortality and survival in adults with 22q11.2 deletion syndrome |
title_sort | all-cause mortality and survival in adults with 22q11.2 deletion syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774995/ https://www.ncbi.nlm.nih.gov/pubmed/30948858 http://dx.doi.org/10.1038/s41436-019-0509-y |
work_keys_str_mv | AT vanlily allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT heungtracy allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT graffijustin allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT ngenoch allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT maleckisarah allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT vanmilspencer allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT booterik allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT corralmaria allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT chowevawc allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT hodgkinsonkathleena allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT silversidescandice allcausemortalityandsurvivalinadultswith22q112deletionsyndrome AT bassettannes allcausemortalityandsurvivalinadultswith22q112deletionsyndrome |